Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

View source ↗

Summary

A clinical trial update describes a study of ozanimod in pregnant women with ulcerative colitis and their offspring; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Status: NOT_YET_RECRUITING